NMD-VCell Neuromuscular Virtual Cell Research Platform Module: Registry · Evidence → perturbation → experiment → outcome NMD = neuromuscular disorders

Release 2026.08DMD context observedDMD candidate-conditioned prediction not yet eligible

View scientific status
Evidence freeze: 3 August 2026 Resource: v1.2.0-measured-dmd-evidence Schema: 1.1 Open release status →

Scientific program

Scientific program · released contract

How NMD-VCell will test whether a perturbation changes DMD muscle function.

The core object is now perturbation × cell state × disease context × time × phenotype. A gene alone is not the unit of biological validation.

Two tracks · separate gates

General virtual-cell performance and DMD validity cannot substitute for one another

Competition Generalist Track

Transport across contexts

Unseen perturbation, donor, state, dataset and calibrated abstention. Primary outputs are pseudobulk response and, when cell-level truth exists, a predicted cell population.

Inspect generalization tasks

DMD Scientific Track

Replicate disease-relevant function

DMD and matched control, functional primary endpoint, target engagement, toxicity, reagent concordance, donor heterogeneity and prospective outcome registration.

Inspect pilot contract

Mechanism chain

Every priority perturbation must connect early mechanism to late function

Perturbationdirection, modality, dose and engagement
6–12 hearly molecular response
24–48 hregulatory program and state transition
4–7 dfunction, toxicity and cross-cell consequence

These windows are planning defaults and must be calibrated to the selected cell system before registration.

Flagship studies

Three research programs, each shown at its declared scientific state

DMD-MIN-PERTURBOME

DMD Minimum Perturbome

Which perturbations produce reproducible DMD-relevant functional effects?

Designed, not yet completedPANEL_DRAFT_ASSIGNED_SIGNOFF_PENDING
DMD-STATE-ATLAS

DMD State-Specific Perturbation Atlas

How do perturbation effects change across myogenic state, time and microenvironment?

Designed, not yet completedREGISTERED_DATA_MODEL_DATA_MISSING
NMD-PROSPECTIVE-CHALLENGE

Prospective NMD-VCell Challenge

Does frozen model selection improve future experimental hit rate over random, expert and simple baselines?

Designed, not yet completedREGISTERED_FRAMEWORK_NO_PREDICTIONS_OR_OUTCOMES

Governed evidence transition

The next release is earned by outcomes, not by adding pages

STUDY CARDeditable design drafts
REGISTERED STUDYnext immutable object
EXPERIMENTruns after registration
OUTCOMEsupportive, null, toxic or inconclusive
TRANSITIONgoverned evidence update
Current boundary. v1.0 is a database and evidence-governance release; it is not a validated disease-prediction or clinical decision-support release. This program object adds a preregistration and evaluation contract; it does not add experimental evidence.

Reusable scientific figures

Units, uncertainty and source tables are first-class objects

Seven registered views cover all six priority classes: source effects, dataset-task-result coverage, reported sample/donor distributions, trajectory-time alignment, benchmark intervals and selective risk-coverage.

Execution ledger

Software completion and external evidence events are tracked separately

All 35 planned upgrades now have a deliverable, validation state and named external dependency where required.

Open execution ledger